BEX‑303
Multidrug‑Resistant Bacterial Infections
PreclinicalActive
Key Facts
Indication
Multidrug‑Resistant Bacterial Infections
Phase
Preclinical
Status
Active
Company
About Beximco Pharmaceuticals
South Korean biotech leveraging AI‑driven small‑molecule drugs for metabolic and infectious diseases.
View full company profile